Ftse Mib
34.790,39
-0,85%
DAX
20.154,57
-0,33%
S&P 500
5.796,39
-0,53%
NASDAQ
18.908,17
-1,32%
Bitcoin
91.458,00
-3,21%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Maia Biotechnology Inc (MAIA) Maia Biotechnology Inc (MAIA) Notizie

MAIA

Maia Biotechnology (MAIA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MAIA
DataOraFonteTitoloSimboloCompagnia
10/01/202515:45Business WireMAIA Biotechnology to Present at Biotech Showcase 2025AMEX:MAIAMaia Biotechnology Inc
07/01/202515:12Business WireMAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer IndicationsAMEX:MAIAMaia Biotechnology Inc
03/01/202522:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:MAIAMaia Biotechnology Inc
23/12/202422:51Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
23/12/202422:49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:MAIAMaia Biotechnology Inc
19/12/202414:47Business WireMAIA Biotechnology Announces Director Participation in Recent Private Placement ClosingsAMEX:MAIAMaia Biotechnology Inc
16/12/202414:37Business WireMAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade GliomasAMEX:MAIAMaia Biotechnology Inc
10/12/202400:00Business WireMAIA Biotechnology Announces Private Placement of Approximately $950,000AMEX:MAIAMaia Biotechnology Inc
03/12/202414:17Business WireMAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
12/11/202422:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:MAIAMaia Biotechnology Inc
12/11/202418:54Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:MAIAMaia Biotechnology Inc
07/11/202414:47Business WireMAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private PlacementAMEX:MAIAMaia Biotechnology Inc
05/11/202415:45Business WireMAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual MeetingAMEX:MAIAMaia Biotechnology Inc
29/10/202400:00Business WireMAIA Biotechnology Announces $2.44 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
26/10/202400:16Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:MAIAMaia Biotechnology Inc
25/10/202423:12Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipAMEX:MAIAMaia Biotechnology Inc
15/10/202414:15Business WireMAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer TherapeuticsAMEX:MAIAMaia Biotechnology Inc
10/09/202412:00Business WireMAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
04/09/202414:30Business WireMAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:MAIAMaia Biotechnology Inc
23/07/202410:11Business WireMAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment AgentAMEX:MAIAMaia Biotechnology Inc
07/06/202418:31Business WireMAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent TherapyAMEX:MAIAMaia Biotechnology Inc
06/06/202416:07Business WireMAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer AgentAMEX:MAIAMaia Biotechnology Inc
04/06/202414:41Business WireMAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
17/05/202414:37Business WireMAIA Biotechnology to Present at the BIO International Convention 2024AMEX:MAIAMaia Biotechnology Inc
16/05/202414:37Business WireMAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual MeetingAMEX:MAIAMaia Biotechnology Inc
30/04/202414:08Business WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
29/04/202414:08Business WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private PlacementAMEX:MAIAMaia Biotechnology Inc
23/04/202414:51Business WireMAIA Biotechnology Announces $1.00 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
05/04/202414:01Business WireMAIA Biotechnology to Present at Two Investor Conferences in April 2024AMEX:MAIAMaia Biotechnology Inc
28/03/202420:00Business WireMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro GuerreroAMEX:MAIAMaia Biotechnology Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MAIA

La tua Cronologia

AMEX
APUE
Activepassive US Equity ...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network